A Study of Preferences of Participants and Oncologists for the Characteristics of the Treatment for Renal Cell Carcinoma (RCC) In Spain And Portugal

Inclusion Criteria

• •For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com
• •The oncologist is currently working in a Spanish or Portuguese public hospital.
• •The oncologist has at least 2 years of experience in the management of participants with Renal Cell Carcinoma (RCC).
• •The oncologist has agreed to participate in the study.
• •The participant has been diagnosed with RCC for a minimum of 2 months before study inclusion.
• •The participant has received or is currently receiving pharmacological treatment for RCC;
• •The participant has provided the informed consent to participate in the study.
• •The participant must be able to read, understand and complete the survey instrument according to the judgment of the responsible physician.